Guaifenesin Tablet, Extended Release
Product Images NDC 69848-017

1 FDA label image from Granules Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 69848-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

20ct (600mg 20ct)

20ct (600mg 20ct)
Packaging label for Guaifenesin Extended-Release Tablets 600 mg by Granules USA, Inc. The label shows 20 extended-release bi-layer tablets with a 12-hour effect. It highlights relief of chest congestion, thinning and loosening of mucus, and immediate plus extended release. The label includes drug facts, warnings, directions, inactive ingredients, and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.